오스트레일리아 - 영어 - APVMA (Australian Pesticides and Veterinary Medicines Authority)

bayer cropscience pty ltd - coumatetralyl - bait - coumatetralyl coumarin active 0.37 g/kg - vertebrate poison - home - mouse - mus spp. | rat

이스라엘 - 영어 - Ministry of Health

bayer israel ltd - clotrimazole - cream - clotrimazole 1 %w/w - clotrimazole - for the treatment of fungal infections of the skin and mucosa caused by dermatophytes, yeasts, moulds and other fungi such as malassezia furfur as well as skin infections caused by corynebacterium minutissimum. indicated also for candida vulvitis and candida balanitis.

이스라엘 - 영어 - Ministry of Health

bayer israel ltd - iloprost - solution for inhalation - iloprost 0.01 mg/ml - iloprost - treatment of patients with primary pulmonary hypertension (pph) or secondary pulmonary hypertension (sph) . due to connective tissue disease or drug - induced, in moderate or severe stages of the disease. in addition, treatment of moderate or severe secondary pulmonary hypertension due to chronic pulmonary thromboembolism, where surgery is not possible.

이스라엘 - 영어 - Ministry of Health

bayer israel ltd - darolutamide - film coated tablets - darolutamide 300 mg - darolutamide - nubeqa ,in combination with adt is indicated for the treatment of adult men with non metastatic castration resistant prostate cancer (nmcrpc) who are at high risk of developing metastatic disease nubeqa is indicated for the treatment of adult patients with metastatic hormone-sensitive prostate cancer (mhspc) in combination with docetaxel

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

bayer australia ltd - moxifloxacin, quantity: 1.6 mg/ml (equivalent: moxifloxacin hydrochloride, qty 1.744 mg/ml) - injection, intravenous infusion - excipient ingredients: hydrochloric acid; sodium chloride; water for injections; sodium hydroxide - avelox (moxifloxacin hydrochloride) tablets are indicated for the treatment of adults with infections caused by susceptible organisms in the conditions. acute bacterial sinusitis, community acquired pneumonia, acute exacerbations of chronic bronchitis. avelox iv (moxifloxacin hydrochloride) intravenous solutions are indicated for treatment of adults who require initial iv therapy for the treatment of infections in the conditions. community acquired pneumonia (caused by susceptible organisms). acute exacerbations of chronic bronchitis when caused by organisms bacteriologically proven to be resistant to other classes of antibiotics or when there is intolerance to other antibiotics. avelox iv (moxifloxacin hydrochloride) intravenous solutions are indicated for treatment of adults with severe and complicated skin and skin structure infections who require initial parenteral therapy, and who have intolerance to alternative agents. (especially penicillin allergy), and when caused by organisms known to be susceptible to moxifloxacin. appropriate culture and susceptibility tests should be performed before treatment in order to isolate and identify organisms causing infection and to determine their susceptibility to moxifloxacin. therapy with moxifloxacin may be initiated. in some conditions, before results of these tests are known. once results become available, therapy should be continued with the most appropriate antibiotic therapy.

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

bayer australia ltd - moxifloxacin, quantity: 1.6 mg/ml (equivalent: moxifloxacin hydrochloride, qty 1.744 mg/ml) - injection, intravenous infusion - excipient ingredients: water for injections; sodium chloride; sodium hydroxide; hydrochloric acid - avelox (moxifloxacin hydrochloride) tablets are indicated for the treatment of adults with infections caused by susceptible organisms in the conditions. acute bacterial sinusitis, community acquired pneumonia, acute exacerbations of chronic bronchitis. avelox iv (moxifloxacin hydrochloride) intravenous solutions are indicated for treatment of adults who require initial iv therapy for the treatment of infections in the conditions. community acquired pneumonia (caused by susceptible organisms). acute exacerbations of chronic bronchitis when caused by organisms bacteriologically proven to be resistant to other classes of antibiotics or when there is intolerance to other antibiotics. avelox iv (moxifloxacin hydrochloride) intravenous solutions are indicated for treatment of adults with severe and complicated skin and skin structure infections who require initial parenteral therapy, and who have intolerance to alternative agents. (especially penicillin allergy), and when caused by organisms known to be susceptible to moxifloxacin. appropriate culture and susceptibility tests should be performed before treatment in order to isolate and identify organisms causing infection and to determine their susceptibility to moxifloxacin. therapy with moxifloxacin may be initiated. in some conditions, before results of these tests are known. once results become available, therapy should be continued with the most appropriate antibiotic therapy.

이스라엘 - 영어 - Ministry of Health

bayer israel ltd - clotrimazole - vaginal tablets - clotrimazole 200 mg - clotrimazole - clotrimazole - infections in external female genital organs and vagina caused by clotrimazole-sensitive microorganisms such as fungi (candida albicans) and trichomonas.during treatment of vaginitis caused by trichomonas, canesten v must be combined with an oral trichomonacide (e.g metronidazole).

이스라엘 - 영어 - Ministry of Health

bayer israel ltd - clotrimazole - vaginal tablets - clotrimazole 200 mg - clotrimazole - clotrimazole - infections in external female genital organs and vagina caused by clotrimazole-sensitive microorganisms such as fungi (candida albicans) and trichomonas.during treatment of vaginitis caused by trichomonas, canesten v must be combined with an oral trichomonacide (e.g metronidazole).

이스라엘 - 영어 - Ministry of Health

bayer israel ltd - vardenafil as hydrochloride trihydrate - film coated tablets - vardenafil as hydrochloride trihydrate 10 mg - vardenafil - vardenafil - treatment of erectile dysfunction, which is the inability to achieve or maintain a penile erection sufficient for satisfactory sexual performance. in order for levitra to be effective, sexual stimulation is required. not indicated for use by women.

이스라엘 - 영어 - Ministry of Health

bayer israel ltd - vardenafil as hydrochloride trihydrate - film coated tablets - vardenafil as hydrochloride trihydrate 20 mg - vardenafil - vardenafil - treatment of erectile dysfunction, which is the inability to achieve or maintain a penile erection sufficient for satisfactory sexual performance. in order for levitra to be effective, sexual stimulation is required. not indicated for use by women.